Chronic obstructive pulmonary disease.
Anzueto
A
A
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use; D001372:Aza Compounds; D017281:Cost of Illness; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000191:economics / Q000209:etiology / Q000503:physiopathology*; D008297:Male; D000077266:Moxifloxacin; D011804:Quinolines; D012907:Smoking / Q000009:adverse effects
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin